Vnitr Lek 1995, 41(9):605-608

[Betaxolol hydrochloride in the treatment of mild and medium hypertension--long-term effects].

M Soucek, J Julínek, I Rihácek, M Stejfa
I. interní klinika Nemocnice u sv. Anny, Brno.

All available beta-blockers are effective in the treatment of high blood pressure. Differences in the pharmacokinetics are important as they can have an impact on their clinical use. Betaxolol, a beta-1-selective blocker has a long biological half-life which can control the blood pressure and pulse rate for 24 hours. The authors investigated 20 patients with mild and medium severe hypertension by out-patient monitoring of the blood pressure. Treatment was focused on influencing the morning rise of blood pressure and pulse rate. The results confirm the effectiveness of betaxolol (Lokren) in the administered dose of 10-20 mg once per day. A favourable response was obtained in 75% when checked by a sphygmomanometer. The morning readings of blood pressure at 5, 6 and 7 o'clock following treatment did not exceed 90 mmHg diastolic pressure. It was also found that there is a statistically significant difference in the effect exerted on pressure and pulse rate in daytime, while the difference at nighttime is not significant. This mild reduction on blood pressure and pulse rate during the night is an advantage in particular in elderly patients. Lokren treatment did not have any serious side-effects it did not affect laboratory values or ECG with the exception of the pulse rate.

Keywords: Adrenergic beta-Antagonists, therapeutic use, ; Adult; Betaxolol, therapeutic use, ; Blood Pressure, drug effects, ; Female; Humans; Hypertension, drug therapy, ; Male; Middle Aged

Published: September 1, 1995  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Soucek M, Julínek J, Rihácek I, Stejfa M. [Betaxolol hydrochloride in the treatment of mild and medium hypertension--long-term effects]. Vnitr Lek. 1995;41(9):605-608.
Download citation




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.